📊 Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
20
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
67%
💰 Capital Raise
73%
• Critical: only 1.6 months cash remaining
• Active ATM program with $250M remaining capacity
🔄 Reverse Split
70%
• 50-day avg $0.74 below $1 exchange minimum
• Only 2 months cash — financial pressure
📉 Score Deterioration
50%
• Score rose 52 points recently (worsening)
• Score in HIGH risk zone (71/100)
💹 Market Data
Market Cap$17.98M
Shares Outstanding27.45M
Float26.96M
Cash$4.59M
Debt$808.2K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 16.8% shares (2025Q4 vs prior)
18 institutional holders · 6.93M shares
#1
ARMISTICE CAPITAL, LLC
5.58M shares
#2
VANGUARD GROUP INC
597.0K shares
#3
GEODE CAPITAL MANAGEMENT, LLC
220.0K shares
+ 15 more holders Sign up free to view →
📉 Short Interest
Short Interest5.16M
Days to Cover6.8
% of Float19.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Sep 10, 2025
xbrl
XBRL CONVERTIBLE
Sep 30, 2016
424B5
ATM
Apr 24, 2026
8-K
8K EVENT
Apr 24, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CTXR
📊 CTXR FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CTXR Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.